경제적 효과

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (새로운 창 열기)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

Source‎: Anaesthesia 2019;74(12):1534-41.

Indexed‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (새로운 창 열기)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (새로운 창 열기)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Source‎: Blood Adv. 2022;6(3):785-92.

Indexed‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (새로운 창 열기)

혈액학과

경제적 효과

한국어

경제적 효과

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (새로운 창 열기)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (새로운 창 열기)

병원 교섭 위원회(HLC)

의학 자료집

동영상

경제적 효과

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (새로운 창 열기)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (새로운 창 열기)

병원 교섭 위원회(HLC)

의학 자료집

동영상

언어를 선택하세요

공유